Catalyst Wire Dossier Catalyst Wire Dossier

Valsartan/amlodipine fixed-dose combination

Valsartan/amlodipine · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valsartan/amlodipine fixed-dose combination, covering 2017-02-23 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy [Phase 4]

See pricing